Filing Details

Accession Number:
0001596783-20-000230
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-12-23 07:19:58
Reporting Period:
2020-12-21
Accepted Time:
2020-12-23 07:19:58
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1596783 Catalent Inc. CTLT Pharmaceutical Preparations (2834) 208737688
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1612357 Aristippos Gennadios C/O Catalent, Inc.
14 Schoolhouse Road
Somerset NJ 08873
President Softgel & Oral Tech No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-12-21 3,936 $24.44 55,361 No 4 M Direct
Common Stock Disposition 2020-12-21 3,936 $102.95 51,425 No 4 S Direct
Common Stock Acquisiton 2020-12-21 9,726 $36.02 61,151 No 4 M Direct
Common Stock Disposition 2020-12-21 9,726 $102.80 51,425 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Options to purchase Common Stock Disposition 2020-12-21 3,936 $0.00 3,936 $24.44
Common Stock Options to purchase Common Stock Disposition 2020-12-21 9,726 $0.00 9,726 $36.02
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2026-07-26 No 4 M Direct
3,243 2027-07-24 No 4 M Direct
Footnotes
  1. This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in order to implement a plan of financial diversification.
  2. Includes restricted stock units.
  3. Shares sold pursuant to the Rule 10b5-1 trading plan noted in footnote 1.
  4. Volume-weighted average price. These shares were sold in multiple transactions at prices ranging from $102.55 to $103.39, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  5. Volume-weighted average price. These shares were sold in multiple transactions at prices ranging from $102.50 to $103.39, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  6. On July 26, 2016, the reporting person was granted options to purchase 15,735 shares of common stock of the Issuer which vest and become exercisable in four equal installments beginning July 26, 2017.
  7. The options vest in four equal annual installments beginning on July 24, 2018.